Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
ix. lappuse
... FOOD AND DRUGS is composed of nine volumes . The parts in these volumes are arranged in the following order : Parts ... Drug Administration , Department of Health and Human Services . The ninth volume , containing part 1300 to end , in- ...
... FOOD AND DRUGS is composed of nine volumes . The parts in these volumes are arranged in the following order : Parts ... Drug Administration , Department of Health and Human Services . The ninth volume , containing part 1300 to end , in- ...
3. lappuse
... FOOD AND DRUG ADMINISTRATION , DEPARTMENT OF HEALTH AND HUMAN SERVICES - Continued ( Parts 300 to 499 ) EDITORIAL NOTE : The Food and Drug Administration published a document at 49 FR 41019 , Oct. 19 , 1984 , establishing July 1 , 1987 ...
... FOOD AND DRUG ADMINISTRATION , DEPARTMENT OF HEALTH AND HUMAN SERVICES - Continued ( Parts 300 to 499 ) EDITORIAL NOTE : The Food and Drug Administration published a document at 49 FR 41019 , Oct. 19 , 1984 , establishing July 1 , 1987 ...
7. lappuse
... Drugs § 300.50 Fixed - combination tion drugs for humans . prescrip- The Food and Drug Administration's policy in administering the new - drug , antibiotic , and other regulatory provi- sions of the Federal Food , Drug , and Cosmetic ...
... Drugs § 300.50 Fixed - combination tion drugs for humans . prescrip- The Food and Drug Administration's policy in administering the new - drug , antibiotic , and other regulatory provi- sions of the Federal Food , Drug , and Cosmetic ...
9. lappuse
... Food and Drugs . ( e ) The term person includes individ- uals , partnerships , corporations , and associations . ( f ) The definitions and interpreta- tions of terms contained in section 201 of ... Food and Drug Administration , HHS §310.3.
... Food and Drugs . ( e ) The term person includes individ- uals , partnerships , corporations , and associations . ( f ) The definitions and interpreta- tions of terms contained in section 201 of ... Food and Drug Administration , HHS §310.3.
10. lappuse
... drug shall not be deemed to be subject to section 505 of the act if it is a drug licensed under the Public Health ... Food and Drug Administra- tion's conclusions on the effectiveness of drugs are currently being published in the FEDERAL ...
... drug shall not be deemed to be subject to section 505 of the act if it is a drug licensed under the Public Health ... Food and Drug Administra- tion's conclusions on the effectiveness of drugs are currently being published in the FEDERAL ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning